Brought to you by 
Private equity group acquires Biomet
Dec 2006
Executive Summary
A private equity consortium consisting of the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co., and Texas Pacific Group is buying orthopedic device firm Biomet for $10.8bn in cash, or $44 for each outstanding common share (a 9% premium).
Deal Industry
- Biotechnology
-
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Payment Includes Cash
- Buy-out
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Private equity group acquires Biomet
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice